What's new

Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised

May 2, 2025 - 15:22
 0
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Another NC brewery files for bankruptcy

Next Article

More Headaches For Tesla: Mack Truck Muscles Into The Class 8 Electric Truck Market

Related Posts

Human medicines European public assessment report (EPAR): Brilique, ticagrelor, Date of authorisation: 03/12/2010, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0

Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Advisory functions

Advisory functions

May 2, 2025  0